-
Loading metrics
Open Access
Peer-reviewed
Research Article
A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer
-
Daniele Campa ,
* E-mail: d.campa@dkfz.de
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Myrto Barrdahl,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Konstantinos K. Tsilidis,
Affiliations Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
⨯ -
Gianluca Severi,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Carlton South, Victoria, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia
⨯ -
W. Ryan Diver,
Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America
⨯ -
Afshan Siddiq,
Affiliation Imperial College, London, United Kingdom
⨯ -
Stephen Chanock,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
⨯ -
Robert N. Hoover,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
⨯ -
Regina G. Ziegler,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
⨯ -
Christine D. Berg,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
⨯ -
Saundra S. Buys,
Affiliation Division of Oncology, Huntsman Cancer Institute at the University of Utah School of Medicine, Salt Lake City, Utah, United States of America
⨯ -
Christopher A. Haiman,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Brian E. Henderson,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Fredrick R. Schumacher,
Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America
⨯ -
Loïc Le Marchand,
Affiliation University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America
⨯ -
Dieter Flesch-Janys,
Affiliations Department of Cancer Epidemiology/Clinical Cancer Registry, University Cancer Center Hamburg (UCCH), Germany, Department of Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Germany
⨯ -
Sara Lindström,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
David J. Hunter,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Susan E. Hankinson,
Affiliations Harvard School of Public Health, Boston, Massachusetts, United States of America, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Division of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Massachusetts, United States of America
⨯ -
Walter C. Willett,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
Peter Kraft,
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
⨯ -
David G. Cox,
Affiliations Imperial College, London, United Kingdom, Université de Lyon, Université Lyon 1, Lyon, France, Institut National de la Santé et de la Recherche Médicale U1052 Centre de Recherche en Cancérologie de Lyon, Lyon, France, Centre national de la recherche scientifique UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France, Centre Léon Bérard, Lyon, France
⨯ -
Kay-Tee Khaw,
Affiliation Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, Cambridge, United Kingdom
⨯ -
Anne Tjønneland,
Affiliation Danish Cancer Society Research Center, Copenhagen, Denmark
⨯ -
Laure Dossus,
Affiliations Institut National de la Santé et de la Recherche Médicale, Centre for research in Epidemiology and Population Health, Nutrition, Hormones and Women's Health team, Villejuif, France, Université Paris Sud, UMRS 1018, Villejuif, France, Institut Gustave-Roussy, F-94805, Villejuif, France
⨯ -
Dimitrios Trichopoulos,
Affiliations Harvard School of Public Health, Boston, Massachusetts, United States of America, Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece, Hellenic Health Foundation, Athens, Greece
⨯ -
Salvatore Panico,
Affiliation Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy
⨯ -
Carla H. van Gils,
Affiliation Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
⨯ -
Elisabete Weiderpass,
Affiliations Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway, Department of Research, Cancer Registry of Norway, Oslo, Norway, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Samfundet Folkhälsan, Helsinki, Finland
⨯ -
Aurelio Barricarte,
Affiliations Navarre Public Health Institute, Pamplona, Spain, Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain
⨯ -
Malin Sund,
Affiliation Department of Surgery, Umeå University Hospital, Umeå, Sweden
⨯ -
Mia M. Gaudet,
Affiliation Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America
⨯ -
Graham Giles,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Carlton South, Victoria, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia
⨯ -
Melissa Southey,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Carlton South, Victoria, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia
⨯ -
Laura Baglietto,
Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Carlton South, Victoria, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia
⨯ -
Jenny Chang-Claude,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ -
Rudolf Kaaks,
Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
⨯ - [ ... ],
-
Federico Canzian
Affiliation Genomic Epidemiology Group, German Cancer Research Center, Heidelberg, Germany
⨯ - [ view all ]
- [ view less ]
A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer
- Daniele Campa,
- Myrto Barrdahl,
- Konstantinos K. Tsilidis,
- Gianluca Severi,
- W. Ryan Diver,
- Afshan Siddiq,
- Stephen Chanock,
- Robert N. Hoover,
- Regina G. Ziegler,
- Christine D. Berg
- Published: February 11, 2014
- https://doi.org/10.1371/journal.pone.0085955